Use of § 112(a) rejections on antibody patents
By Katy Pearson
A patent property right gives the patentee the “right to exclude others from making, using, selling, offering for sale, and importing the invention into the country [for a statutory period of time].”[1] The quid pro quo for a private right to exclusion is that the patentee provides “a clear and enabling disclosure” of the invention to the public “for the benefit of society.”[2]